Christopher P Leamon's Net Worth

$5.85 Million

Estimate Recalculated Sep 8, 2024 07:23PM EST

Who is Christopher P Leamon?

Christopher P Leamon has an estimated net worth of $5.85 Million. This is based on reported shares across multiple companies, which include Fusion Pharmaceuticals Inc., and ENDOCYTE INC.

SEC CIK

Christopher P Leamon's CIK is 0001509415

Past Insider Trading and Trends

2018 was Christopher P Leamon's most active year for acquiring shares with 11 total transactions. Christopher P Leamon's most active month to acquire stocks was the month of January. 2018 was Christopher P Leamon's most active year for disposing of shares, totalling 31 transactions. Christopher P Leamon's most active month to dispose stocks was the month of November. 2018 saw Christopher P Leamon paying a total of $567,598.15 for 186,640 shares, this is the most they've acquired in one year. In 2018 Christopher P Leamon cashed out on 788,296 shares for a total of $13,267,107.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Fusion Pharmaceuticals Inc. (FUSN) No price found

Chief Scientific Officer

Christopher P Leamon used to own units in Common Stock but no longer holds any shares there. From 2021 to 2024 Christopher P Leamon acquired a total of 11,957 shares in Fusion Pharmaceuticals Inc., Christopher also disposed a total of 11,957 shares of Fusion Pharmaceuticals Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-11.96K
—
—
0
Jun 4
Form 4
∞
11.96K
—
—
11.96K
Aug 31 - Jan 4
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Nov 1
Form 3
—
0
—
—
0
No matching records found

ENDOCYTE INC No price found

Vice President Research

Christopher P Leamon used to own units in Common Stock but no longer holds any shares there.acquired a total of 327,747 shares in ENDOCYTE INC at a cost of $773,901.24, Christopher also disposed a total of 348,192 shares of ENDOCYTE INC equalling to $6,626,071.68.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-224.26K
$24.00
-$5,382,144.00
0
Dec 21
Form 4
+83.09%
101.77K
$5.14
$523,488.51
224.26K
Dec 17
Form 4/A
-6.88%
-9.03K
$15.56
-$140,436.86
122.22K
Scheduled
Oct 5
Form 4
-6.92%
-9.03K
$15.56
-$140,436.86
121.35K
Scheduled
Oct 5
Form 4
—
0
$11.27
-$303,212.89
130.38K
Scheduled
Aug 28 - Aug 29
Form 4
-9.12%
-13.09K
$15.06
-$197,057.51
130.38K
Scheduled
Jun 12
Form 4
-3.39%
-5.04K
$9.07
-$45,676.52
143.47K
Scheduled
Mar 9
Form 4
+17.26%
21.86K
$3.00
-$1,914.00
148.51K
Feb 6 - Feb 8
Form 4
-2.48%
-3.22K
$3.12
-$10,055.76
126.64K
Feb 2 - Feb 4
Form 4
+2.37%
2.95K
$4.05
-$36,878.22
127.35K
Dec 1
Form 4
+47.39%
40K
—
—
124.4K
Oct 4
Form 4
-3.06%
-2.58K
$2.18
-$5,628.76
81.9K
Feb 4 - Feb 6
Form 4
+26.13%
17.5K
—
—
84.48K
Feb 2
Form 4
+4.58%
2.93K
$2.33
-$4,298.40
66.98K
Dec 30
Form 4
+27.01%
13.09K
$1.91
$24,999.99
61.55K
Feb 17
Form 4
+16.81%
6.97K
$3.12
-$5,536.48
48.46K
Feb 4 - Feb 6
Form 4
+48.90%
13.09K
$1.91
$24,999.99
39.85K
Feb 10
Form 4
+43.05%
8.05K
$5.14
-$3,572.30
26.77K
Feb 4 - Feb 6
Form 4
+74.46%
7.5K
—
—
17.57K
Feb 6
Form 4
-33.17%
-5.00K
$14.70
-$73,500.00
10.07K
May 14
Form 4
—
0
—
—
0
Feb 19
Form 4
-39.88%
-10.00K
$9.65
-$96,535.00
15.07K
Aug 16
Form 4
—
0
—
—
0
Feb 29
Form 4
+24.91%
5K
$3.14
$15,700.00
25.07K
Dec 21
Form 4
—
0
—
—
0
Apr 14
Form 4
∞
20.07K
$0.28
$5,524.63
20.07K
Mar 24
Form 4
—
0
—
—
0
Mar 11
Form 3
—
0
—
—
0
No matching records found